HindBio Science
Fundamental Score
HindBio Science Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of HINDIBIO across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
17 factors identified
Suboptimal ROCE (2.95%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-31.13%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 297.13x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-175.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Growth History (-16.03% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (4.56% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (4.56% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Elevated Debt Levels (D/E: 3.05)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-1.02 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (12.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
Very High Debt Levels
Observation: Excessive leverage may strain cash flows.
Analysis: Debt-to-equity above 2.0 indicates potential financial distress risk.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for HindBio Science
About HINDIBIO
Company Details
HINDIBIO Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of HindBio Science (HINDIBIO)?
As of 02 Jan 2026, 03:53 pm IST, HindBio Science (HINDIBIO) is currently trading at ₹5.80. The stock has a market capitalization of ₹5.94 (Cr).
Is HINDIBIO share price Overvalued or Undervalued?
HINDIBIO is currently trading at a P/E ratio of 297.13x, compared to the industry average of 36.75x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the HindBio Science share price?
Key factors influencing HINDIBIO's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is HindBio Science a good stock for long-term investment?
HindBio Science shows a 5-year Profit Growth of 4.56% and an ROE of 11.76%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 3.05 before investing.
How does HindBio Science compare with its industry peers?
HindBio Science competes with major peers in the Software Products. Investors should compare HINDIBIO's P/E of 297.13x and ROE of 11.76% against the industry averages to determine its competitive standing.
What is the P/E ratio of HINDIBIO and what does it mean?
HINDIBIO has a P/E ratio of 297.13x compared to the industry average of 36.75x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹297 for every ₹1 of annual earnings.
How is HINDIBIO performing according to Bull Run's analysis?
HINDIBIO has a Bull Run fundamental score of N/A/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does HINDIBIO belong to?
HINDIBIO operates in the Software Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting HindBio Science.
What is Return on Equity (ROE) and why is it important for HINDIBIO?
HINDIBIO has an ROE of 11.76%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently HindBio Science generates profits from shareholders' equity.
How is HINDIBIO's debt-to-equity ratio and what does it indicate?
HINDIBIO has a debt-to-equity ratio of 3.05, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is HINDIBIO's dividend yield and is it a good dividend stock?
HINDIBIO offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has HINDIBIO grown over the past 5 years?
HINDIBIO has achieved 5-year growth rates of: Sales Growth -16.03%, Profit Growth 4.56%, and EPS Growth 4.56%.
What is the promoter holding in HINDIBIO and why does it matter?
Promoters hold 12.19% of HINDIBIO shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is HINDIBIO's market capitalization category?
HINDIBIO has a market capitalization of ₹6 crores, placing it in the Small-cap category.
How volatile is HINDIBIO stock?
HINDIBIO has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for HINDIBIO?
HINDIBIO has a 52-week high of ₹N/A and low of ₹N/A.
What is HINDIBIO's operating profit margin trend?
HINDIBIO has a 5-year average Operating Profit Margin (OPM) of -31.13%, indicating the company's operational efficiency.
How is HINDIBIO's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of -175.00%.
What is the institutional holding pattern in HINDIBIO?
HINDIBIO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.